Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
82.1 EUR | +2.50% | +2.75% | +3.79% |
Apr. 02 | Bernstein starts AstraZeneca at 'outperform' | AN |
Feb. 22 | Transcript : Kerry Group plc Presents at 2024 Consumer Analyst Group of New York Conference, Feb-22-2024 10:00 AM |
Strengths
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.79% | 14.91B | - | ||
-1.55% | 95.17B | C+ | ||
+4.30% | 46.28B | C+ | ||
+1.84% | 40.93B | B- | ||
+9.93% | 39.98B | B- | ||
+0.91% | 38.2B | B- | ||
-14.76% | 31B | B- | ||
-5.89% | 28.94B | A | ||
+14.15% | 25.4B | A- | ||
-10.70% | 22.48B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- KRZ Stock
- KYGA Stock
- Ratings Kerry Group plc